RICHARD B. LEVINE / Newscom / The Mega Agency
The widely used over-the-counter painkillers ibuprofen and paracetamol could be quietly contributing to one of the worlds most urgent public health crises: antibiotic resistance.
New research from the University of South Australia has found that ibuprofen and paracetamol, commonly sold under the brand name Tylenol, not only drive resistance when used on their own, but may make the problem worse when taken together. The study was published in the journal npj Antimicrobials and Resistance.
In what is believed to be the first study of its kind, researchers assessed how non-antibiotic drugs interact with ciprofloxacin — a broad-spectrum antibiotic commonly prescribed for skin, gut or urinary tract infections — and the common bacterium Escherichia coli (E. coli), which often causes those infections. They discovered that ibuprofen and paracetamol significantly increased bacterial mutations, resulting in E. coli becoming highly resistant not just to ciprofloxacin but to several other antibiotics as well.
Lead researcher Associate Professor Rietie Venter said the findings have serious implications, especially for residential aged care settings where polypharmacy — the simultaneous use of multiple medications — is common.
“Antibiotics have long been vital in treating infectious diseases, but their widespread overuse and misuse have driven a global rise in antibiotic-resistant bacteria,” said Venter. “This is especially prevalent in residential aged care facilities, where older people are more likely to be prescribed multiple medications — not just antibiotics, but also drugs for pain, sleep, or blood pressure — making it an ideal breeding ground for gut bacteria to become resistant to antibiotics.”
In addition to ibuprofen and paracetamol, the study also examined seven other drugs commonly prescribed in aged care: diclofenac (anti-inflammatory for arthritis), furosemide (for high blood pressure), metformin (for blood sugar control), atorvastatin (for cholesterol), tramadol (pain relief), temazepam (for sleep), and pseudoephedrine (a decongestant).
When E. coli was exposed to both ciprofloxacin and common painkillers, researchers observed a spike in genetic mutations that enabled the bacteria to grow more rapidly and resist multiple classes of antibiotics.
“When bacteria were exposed to ciprofloxacin alongside ibuprofen and paracetamol, they developed more genetic mutations than with the antibiotic alone, helping them grow faster and become highly resistant. Worryingly, the bacteria were not only resistant to the antibiotic ciprofloxacin, but increased resistance was also observed to multiple other antibiotics from different classes,” Venter said.
The study also uncovered the mechanism behind this resistance: both ibuprofen and paracetamol activated bacterial defenses that expelled antibiotics from the cells, rendering them far less effective.
“This study is a clear reminder that we need to carefully consider the risks of using multiple medications — particularly in aged care where residents are often prescribed a mix of long-term treatments,” said Venter. “This doesnt mean we should stop using these medications, but we do need to be more mindful about how they interact with antibiotics — and that includes looking beyond just two-drug combinations.”
The World Health Organization has identified antimicrobial resistance as one of the top threats to global health, estimating that antibiotic-resistant bacteria directly caused 1.27 million deaths worldwide in 2019. While much of the focus has been on the overuse of antibiotics themselves, the new findings highlight how non-antibiotic medications may also be playing a role in fueling resistance.